MADONNA: CLUB CONFESSIONS NYC WITH MISTR
July 14, 2026
New York, NY, July 13, 2026 (GLOBE NEWSWIRE) — Everyone here is a work of art. Madonna returned to New York City on this past Saturday night – where it all began
Elevate Marketing Solutions Shares Facebook Advertising Framework Driving Patient Growth for Health and Wellness Practices
July 13, 2026
Land O’ Lakes, Florida, July 13, 2026 (GLOBE NEWSWIRE) — Land O’ Lakes, Florida – July 13, 2026 – Elevate Marketing Solutions, a health and wellness marketing agency specializing in
RMG ML Sports Holdings Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on or about July 17, 2026
July 13, 2026
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) — RMG ML Sports Holdings (Nasdaq: SHOTU) (the “Company”), a special purpose acquisition company, today announced that, commencing on or about July 17,
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
July 13, 2026
New York, USA, July 13, 2026 (GLOBE NEWSWIRE) — Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036)
Family Office Partners Expands into Houston with Addition of Patrick Keller and Andrew C. Keller
July 13, 2026
LAFAYETTE, LA, July 13, 2026 (GLOBE NEWSWIRE) — Family Office Partners, the boutique multifamily office and independent advisory platform backed by the resources of Elevation Point, today announced that Patrick
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
July 13, 2026
Cumulative sales milestones up to $255 million and modest upfront/near-term development milestones Royalties equaling 22% of net sales Ocugen to manufacture and supply OCU400 MALVERN, Pa., July 13, 2026 (GLOBE
Invitation — 2026 Half-Year Results Conference for Analysts and Investors
July 13, 2026
Ladies and Gentlemen, We invite you to the Ascom Holding Ltd Analyst and Investor Conference on the occasion of the publication of the 2026 half-year results: Date: Wednesday, 29 July 2026Start: 10:00
Start of Day Message
July 13, 2026
LONDON, 13 Jul. 2026 (GLOBE NEWSWIRE) — This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved
New Crypto: AlphaPepe Presale Solidifies AI DEX Rollout As XRP Price Prediction Eyes Next Shiba Inu Move
July 13, 2026
MONACO, July 12, 2026 (GLOBE NEWSWIRE) — AlphaPepe is moving deeper into the spotlight as one of the new crypto presales buyers are watching before the next exchange cycle begins.
ROSEN, A LEADING NATIONAL FIRM, Encourages Peabody Energy Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTU
July 12, 2026
NEW YORK, July 12, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Peabody Energy Corporation (NYSE: BTU) between
The 80/20 Institute Introduces an Approach to Expand Margin Without Cutting — by Concentrating on the 20% That Drives Profit
July 12, 2026
Lakewood Ranch, FL, July 12, 2026 (GLOBE NEWSWIRE) — Amid a broad corporate push to “do more with less,” The 80/20 Institute is making a contrarian case for how companies
The 80/20 Institute Releases a 100-Day Playbook for PE-Backed CEOs Under Value-Creation Pressure
July 12, 2026
Lakewood Ranch, FL, July 12, 2026 (GLOBE NEWSWIRE) — Most private-equity value-creation plans do not fail in strategy — they fail in the first 100 days of execution. That is
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
July 12, 2026
The new data demonstrates the potential to improve control of acute infection, latency, and viral reactivation, further supporting the concept behind EVX-V1 EVX-V1 is a next-generation, multi-component vaccine program combining
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
July 12, 2026
HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin
Super Intelligent Valet Parking (SIVP): FREELANDER 8 Enables Effortless Parking for Daily Use
July 12, 2026
SHANGHAI, July 11, 2026 (GLOBE NEWSWIRE) — Chery Group’s FREELANDER 8 was showcased at the Abu Dhabi Investment Forum held at The Peninsula Shanghai last month, attracting strong interest from